Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study.
Bajema KL, Yan L, Li Y, Argraves S, Rajeevan N, Fox A, Vergun R, Berry K, Bui D, Huang Y, Lin HM, Hynes DM, Lucero-Obusan C, Schirmer P, Cunningham F, Huang GD, Aslan M, Ioannou GN.
Bajema KL, et al. Among authors: huang gd.
Lancet Infect Dis. 2025 Jan 20:S1473-3099(24)00796-5. doi: 10.1016/S1473-3099(24)00796-5. Online ahead of print.
Lancet Infect Dis. 2025.
PMID: 39848264